Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1 H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
Boss, Christoph,Brotschi, Christine,Gude, Markus,Heidmann, Bibia,Sifferlen, Thierry,Von Raumer, Markus,Williams, Jodi T.
申请号：
AU2014358743
公开号：
AU2014358743B2
申请日:
2014.12.02
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1 H-benzo[d]imidazol- 2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.
